Abstract #0838

NMR metabolomics of biofluids for early diagnosis of brain metastasis

James R Larkin¹, Alex M Dickens², Timothy D W Claridge³, Daniel C Anthony², and Nicola R Sibson¹

¹CRUK and MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom, ²Department of Pharmacology, University of Oxford, Oxford, United Kingdom, ³Department of Chemistry, University of Oxford, Oxford, United Kingdom

Secondary tumours, or metastases, in the brain are currently detected at a late stage by gadolinium-enhanced MRI. We used mouse models of brain metastases, coupled with high resolution NMR of urine to identify characteristic patterns of metabolites in tumour-bearing animals. A model with a tumour cells implanted directly in the brain showed sensitive and specific detection at day 5 with increasing separation at later time points. Models injecting cells into the heart or venous circulation give rise to differing systemic and central nervous system (CNS) tumour burdens. Metabolite patterns allow identification of these animals with a heavy CNS tumour burden.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.